Regenerative medicine using stem cells offers tremendous potential for treating a range of medical conditions. In the past two decades, researchers have made significant progress, and initial cell-based therapies are now emerging to treat cardiac diseases. However, some less reputable clinics are marketing stem cell treatments with claims that far exceed known benefits.
At this event, moderated by Maya Pomroy of The Public Lead, includes physician-scientists Dr. Deepak Srivastava and Dr. Emerson Perin, who reviewed advances in stem cell research for cardiac care over the last 20 years. Fellow Kirstin R.W. Matthews highlighted the central policy and ethical concerns that have emerged during this period.
This event was part of an annual policy lecture series co-sponsored by the Baker Institute Center for Health and Biosciences and The Texas Heart Institute. Support for the program has been provided by a grant from the George and Mary Josephine Hamman Foundation.
This event was free and open to the public.
Follow @BakerInstitute on X to join the conversation online with #BakerLive.
Registration
Registration has closed.
Baker Institute events are powered by the generous contributions of our supporters. Learn how you can make a donation or become a member of the Baker Roundtable.
Agenda
7:30 am | Reception |
8:00 am | Welcome RemarksVivian Ho, Ph.D. |
8:10 am | Advances in Stem Cell Cardiac ResearchDeepak Srivastava, M.D. |
8:25 am | Advances in Regenerative Medicine Clinical Research for Cardiac CareEmerson Perin, M.D., Ph.D., FACC |
8:40 am | Ethical and Policy Challenges: Reflections on the Past and a Review of Current IssuesKirstin R.W. Matthews, Ph.D. |
8:55 am | Panel DiscussionModerated by: Maya Pomroy, Founder, The Public Lead; Co-founder, Maven Interests; Host, Owl Have You Know Deepak Srivastava, M.D. Emerson Perin, M.D., Ph.D., FACC Kirstin R.W. Matthews, Ph.D. |
9:30 am | Adjourn |